Veradermics
MANE | NYSE
$139.69
-$4.16 (-2.89%)
At close: Oct 30, 2026, 4:00 PM ET
$140.56
+$0.87 (+0.62%)
Pre-market:
Nov 2, 2026, 7:02 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
Net Income | -70M | -26.49M | -16.49M |
Depreciation & Amortization | n/a | n/a | n/a |
Stock-Based Compensation | 1.44M | 250K | 206K |
Other Working Capital | -3.76M | 86K | -434K |
Other Non-Cash Items | 839K | 1.82M | 1.85M |
Deferred Income Tax | n/a | n/a | n/a |
Change in Working Capital | -3.89M | 732K | 920K |
Operating Cash Flow | -71.6M | -23.69M | -13.51M |
Capital Expenditures | -24K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a |
Purchase of Investments | -143.85M | n/a | n/a |
Sales Maturities Of Investments | 25.02M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a |
Investing Cash Flow | -118.86M | n/a | n/a |
Debt Repayment | n/a | 7.66M | n/a |
Common Stock Repurchased | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a |
Other Financial Acitivies | -447K | n/a | -35K |
Financial Cash Flow | 159.14M | 60.48M | 13.9M |
Net Cash Flow | -31.32M | 36.79M | 385K |
Free Cash Flow | -71.63M | -23.69M | -13.51M |
Adj. Free Cash Flow | -73.07M | -23.94M | -13.72M |
Maintenance CapEx | n/a | n/a | n/a |
Growth CapEx | -24K | n/a | n/a |
Owner Earnings | -71.6M | -23.69M | -13.51M |
Add to Watchlist
Select watchlists to add or remove MANE